Coronavirus alert: lockdowns in China, hospitalizations in the United States, etc.

As China on Thursday reported a third straight day of more than 1,000 new COVID-19 cases nationwide, cities from Wuhan in central China to Xining in the northwest sealed off buildings and closed neighborhoods, according to Reuters. As of October 24, 28 cities were implemented forced confinement measures to varying degrees, affecting more than 207 million people. Even though those infection numbers are far from the peak of the pandemic, China has continually pledged to stick to a zero-tolerance reaction to COVID-19 and put in forcing what mandatory government measures to engage the virus.

Forbes’ knowledge research from the Centers for Disease Control and Prevention (CDC) found that an average of 3277 patients with COVID-19 cases were admitted to the hospital every day of the week ending Oct. 24. The number rose 1. 1% from the seven-day average, marking the first accumulation of COVID-19 hospitalizations since July.

The New York Times reported Thursday that about 1,100 more people were hospitalized with the coronavirus in New York City on Oct. 24, up from 750 in mid-September, according to state data. New York City emergency department visits for children under five for respiratory disorders are now at their peak since the first outbreak of omicron last winter, and many have respiratory syncytial virus (RSV) or influenza.

As NBC News reported this week, Boston doctors say XBB, a variant of omicron that has been dubbed a “nightmare variant” in Singapore, is almost already circulating in Massachusetts. The variant is known to be incredibly immune-elusive and it’s unclear whether existing vaccines offer protection. According to Fortune, at least 16 cases have been known in the United States.

Research published this week in a new edition of the CDC’s publication on emerging new diseases indicated that domestic human-to-animal transmission of the coronavirus occurs and that inflamed animals typically show symptoms of illness, such as shortness of breath, coughing or decreased interest in gambling. , walk or eat. Based on tests on 81 dogs and 32 cats from families in which at least one adult had tested positive for COVID-19, researchers found that 40% of the dogs and 43% of the cats were HIV-positive, meaning they had coronavirus antibodies in their blood. Polymerase chain reaction (PCR) tests revealed that 5% of dogs and 8% of cats tested positive for PCR. Pet owners who participated in the study occasionally reported close contact between humans and animals.

The World Health Organization’s (WHO) weekly COVID update estimated that the number of weekly new cases decreased by 15% and weekly new deaths were reduced by 13% globally the week of October 17-23 compared to last week. The WHO said infections have declined or remained robust in all regions of the world. The countries with the highest instances were Germany, France, China, Italy and the United States.

Still, as Reuters reported, global COVID-19 infections are expected to slowly rise to around 18. 7 million through February, compared to the existing average of 16. 7 million cases, driven during the Northern Hemisphere’s winter months, according to research from the University of Washington. .

WHO’s Global TB Report 2022 released on Thursday found that around 10. 6 million people fell ill with tuberculosis (TB) in 2021, a 4. 5% increase from 2020, and 1. 6 million people died from TB. This is the first time in many years that an increase in the number of other people with TB has been reported. WHO noted that the impact of the pandemic on the TB response has been particularly severe.

Analysis of death rates from all causes of death in all 50 states from 1999 to 2019 published in the journal PLoS One found that other people die younger in states with more conservative policies, and more than 171,000 lives may have been stored in 2019 if those states had followed more liberal policies.

The White House aims to update booster shots for seniors and other immunocompromised people to prevent thousands of salvageable deaths, but fitness officials told The Washington Post that management fears COVID exhaustion could lead to a winter surge.

As part of President Biden’s call to action to help save him from severe COVID illness this winter, Walgreens is running with Uber and DoorDash to provide free prescription delivery of Paxlovid, a COVID-19 oral remedy, right on the doorstep of Americans living in underserved communities. . . Patients with a prescription for Paxlovid (nirmatrelvir and ritonavir) at Walgreens who live in a socially vulnerable network, based on CDC’s Social Vulnerability Index, will be able to receive their Paxlovid prescription at home through Uber Health and DoorDash at no charge through Walgreens. com and the Walgreens app.

Singer and actress Selena Gomez posted on Instagram that she would not be making her scheduled appearance on The Tonight Show with Jimmy Fallon because she tested positive for coronavirus and is staying home to rest. Gomez, 30, wrote, “There is still a friendly reminder of COVID. “. Catch up with your reinforcements. In fact, I intended to get mine this week. I love you all. “

According to NBC News this week, pediatricians and children’s hospitals across the country report that a multitude of respiratory viruses are infecting children at the same time and earlier than usual in the season. Cases of influenza, respiratory syncytial virus (RSV), parainfluenza virus, adenovirus, rhinovirus, and enterovirus are increasing. Mark Kline, MD, medical director of Children’s Hospital New Orleans, told NBC that some children contract two or three viruses at once.

CNN reported that a pandemic “immunity gap” may also be causing the outbreak. Measures others have taken to restrict the spread of COVID-19 have also prevented others from contracting other viruses. Reduced exposure to viruses would likely have weakened others. People’s defenses, and as the public abandoned wearing masks and other protective measures, viruses would spread more easily. CNN added that a shortage of pediatric hospital beds is causing delays in caring for some children.

The National Bureau of Economic Research (PDF) published an article this month concluding that considerations about COVID-19 infection prevent about 2% of the U. S. hard workforce from working in the U. S. from working hard. Run or work. Bloomberg News estimated that the percentage is roughly equivalent to 3 million people. Relief in the workforce has claimed the economy about $250 billion this year.

The Center for Infectious Disease Research and Policy shared the results of a study published this week in the journal BMJ Heart indicating that hospitalized COVID-19 patients had a particularly high risk of death, blood clot in a vein, central failure, and stroke within 30 days compared to other uninfected or outpatients with COVID-19 (who receive care without the need for hospitalization). The study involved another 17,871 people who tested positive for the virus between March 2020 and March 2021 and 35,742 were uninfected. Heart attack, stroke, central failure, atrial fibrillation, venous thromboembolism (blood clot in a vein), pericarditis (inflammation of the central mucosa), or death occurred in 9% of COVID-19 patients and 0. 7% of the group. The researchers observed that hospitalized COVID-19 patients were 118 times the threat of death on an outpatient basis.

A study published by the CDC last week showed that for immunocompromised people, the overall coverage provided through vaccination, even with one or two subsequent boosters, is lower than that of adults without immunocompromised conditions. The multistate study found in spring and summer data. 2022, when the subvariants omicron BA. 4 and BA. 5 became dominant. A review of the medical records of 30,000 immunocompromised adults found that coverage against COVID-related hospitalizations was 34% after two doses of the vaccine, rising to 71% on days 7 to 89 after a third dose, and then dropping to 41% at 90 days or more after the same booster dose.

“Although vaccines in the general adult population have been shown to be 70 to 90 percent effective, for immunocompromised people we expect much less diversity — 34 to 71 percent efficacy,” said co-author Brian Dixon, PhD, of the Regenstrief Institute. and the Richard M. Fairbanks School of Public Health at Indiana University, in a press release. “This confirms that, even with boosters, immunocompromised adults, due to their weakened immune systems, remain the main threat of moderate to severe COVID.

On Tuesday, President Joe Biden earned his updated COVID-19 reminder and took the opportunity to inspire all eligible Americans to do the same. Accompanied by executives from some of America’s most sensible pharmacies, plus Walgreens, CVS, Rite Aid and Albertsons, Biden made it clear that very few people were receiving the retreat. Biden under pressure over the importance of getting a recall designed to combat omicron strains, as new variants emerge around the world and more people spend time in combination indoors, making it less difficult. for the virus to spread. ” Your previous vaccine or previous COVID infection will not offer you maximum protection,” the 79-year-old president said. “I call on all Americans to get vaccinated as soon as possible. “

The Institute for Health Metrics and Evaluation at the University of Washington estimates that daily infections in the U. S. are still the most likely to occur. UU. se will accumulate for about a third through February, largely due to a buildup in the spread of the virus in schools and overall seasonality. of winter, according to Tuesday’s San Francisco Chronicle. While infections are expected to rise slowly over the winter, analysts are not predicting the dramatic increases in COVID-19-related hospitalizations and deaths noted in the first two winters of the pandemic.

Data from the National Center for Health Statistics (PDF) released this week showed that COVID-19 death rates were at least 50% higher among men than women in 2020. In giant metropolitan areas, death rates were 78% higher for men. Scientists point to other reasons for the gender difference in COVID-19-related mortality: men tend to have more physical conditions that can contribute to death, which increases high blood pressure and diabetes; women would possibly have a better immune system; And possibly men would be more lax when it comes to following preventive measures such as wearing a mask or getting vaccinated.

CNN said Tuesday that the Department of Health and Human Services is launching classified video, print and radio ads starting this week aimed at audiences that have been slow to adopt updated booster shots. Classified ads look good in black, Latino and rural communities.

With an imaginable surge in infections in the coming colder months, Biden’s management is releasing a fall handbook for businesses (PDF), which contains data on steps businesses of all types can take to protect their staff and consumers and keep their doors open, adding steps they can take to provide staff with their updated COVID-19 vaccine. Educate staff about COVID-19 remedies and improve indoor air quality in your buildings. “We now have the equipment we want to make sure COVID-19 doesn’t control our lives, but we want to keep using it to make sure we can have a safe fall and winter,” the document says.

A study published in the British Journal of Sports Medicine found that physical activity levels matched levels of coverage rather than vaccination. of 60 minutes consistent with the week), 62,721 with medium degrees (60 to 149 minutes consistent with the week) and 79,952 with maximum degrees (more than 150 minutes consistent with the week). The researchers found that vaccine efficacy opposed COVID-related hospitalization in other vaccinated people in the low-activity organization 60%, 72. 1% for the moderately active organization, and 85. 8% for the high-activity organization.

Becker Hospital Review reported on a pre-print study (PDF) released Monday and concluded that bivalent boosters targeting newly licensed microns produced a reaction similar to the fourth dose of the original COVID-19 vaccine formula. The scientists found that about a month after receiving the booster vaccine, participants in real clinical trials who won the new, updated vaccine had “neutralizing antibody titers similar to those who won a fourth monovalent mRNA vaccine. “and the Moderna vaccine last August discovered positive testing effects in mice. Study authors from Columbia University in New York and the University of Michigan in Ann Arbor concluded that more research was needed to determine whether “antibody reactions will vary over time, adding the effect of momentary bivalent reinforcement. “

Late last week, the CDC announced in its weekly COVID Tracker review that they are painstakingly tracking a wide diversity of omicron sublineages, with specific attention paid to 3:BQ. 1, BQ. 1. 1, and XBB. The fitness firm called the BQ variants “grandchildren” of the omicron BA. 5 strain it has dominated for months. CDC knowledge shows that BQ variants appear to be spreading relatively temporarily so far, but still account for a relatively smaller proportion of general variants; Combined, they account for only about 17% of existing cases. Meanwhile, BA. 5 accounts for just over 62% of infections. According to foreign reports, the CDC is also largely tracking a sublineage called XBB, which is still very rare in the United States. “As the virus spreads, it has new opportunities to replace tactics that would possibly make emerging variants harder to prevent because the effectiveness of vaccines or remedies would possibly be reduced,” the CDC wrote.

COVID-19 infections caused by the newly known XBB strain of omicron have nearly doubled in India in a week, The Times of India reported on Sunday. XBB cases in India, which totaled 71 as of Oct. 14, rose to 136 on Oct. 23. According to forecasts, the Times predicted that XBB could be the dominant subvariant in the country within a month.

Singapore recently experienced a wave of XBB, but Eric Topol, MD, founder and director of the Scripps Research Translational Institute, tweeted on Oct. 22 that the variant is now declining in that country. The WHO said it also monitors XBB and is involved in a study. suggesting that XBB has significant immune evasion. “This considers us because we want vaccines used around the world to remain effective in preventing serious illness and death. Therefore, the more this virus circulates, the more opportunities it has to change,” said Maria Van Kerkhove. , PhD, infectious disease epidemiologist and WHO technical lead for the COVID-19 response.

Variant tracker Raj Rajnarayanan, PhD, assistant dean of studies and associate professor on the campus of the New York Institute of Technology in Jonesboro, Arkansas, told Fortune magazine that the existing wave of hospitalization in the state is “quite close, if not greater than, the peak of the delta,” which swept the U. S. Last year, the U. S. government last year. Rajnarayanan cited information from New York indicating that COVID-19 hospitalizations were close to 2000 in mid-September and are now closer to 3,000. He also noted that BQ variants now account for 28% of cases in the CDC’s follow-up area that includes New York and New Jersey.

As CNN reported, President Biden would receive the updated COVID-19 bivalent reminder on Tuesday, which targets the subvariants of omicrons. The CDC recommends that Americans five years of age and older get an updated (bivalent) booster if it has been in less than two months since their last dose of COVID-19 vaccine, either a last dose of series one or an original monovalent booster. Those who have had COVID-19 are kindly requested to wait at least 3 months from the time they were vaccinated. Inflamed for the first time. Biden was last inflamed last July. The new boosters are designed to provide greater coverage compared to omicron subvariants, which can lead to a resurgence of diseases in autumn and winter.

After an outbreak of illness left 1,000 students in poor physical condition last week, Stafford High School in Virginia canceled activities and sporting events to prevent the spread of the disease. Sandra K. Osborn, director of communications for Stafford County Public Schools, said “a number” of academics tested positive for the flu, according to NBC News. As of Monday, 670 academics, nearly a third of the student frame, were still in poor physical condition. Flu season began earlier this year, and fitness officials have predicted that this year’s dominant flu strain may cause more severe illness than other seasons.

Based on tests from thousands of fourth- and eighth-graders across the country, this year’s National Assessment of Educational Progress, known as the “National Report Card,” found that 21 states have below-average math and reading scores for fourth- and third-graders. 8 since the beginning of the pandemic. Nationally, the average math score for fourth grade decreased five problems from 2019 and grade 8 score decreased 8 problems. These two decreases are the largest since evaluation began in 1990. “The effects show the high cost in student learning during the pandemic. . . . They emphasize the importance of training and the role of schools in educational expansion and the overall well-being of students,” tweeted Peggy Carr, PhD, commissioner of the National Center for Education Statistics.

On Saturday, the CDC announced that its director, Rochelle Walensky, MD, MPH, had tested positive for COVID-19. Walensky, who is absolutely up-to-date on his vaccinations, has mild symptoms and self-isolates at home according to CDC guidelines. You will practically participate in your scheduled meetings. Senior CDC officials and close contacts have been notified of their positive control and are taking appropriate steps to monitor their health.

In an investigation published via The New York Times on Sunday, fitness officials said the U. S. is not yet in the U. S. The U. S. could not only suffer a double whammy of flu and COVID-19 cases as the fall progresses, but a triple whammy as an unusually high number of respiratory syncytial virus goes. (RSV) infections are sweeping the country. The number of flus already seems to be emerging faster and earlier than expected, and children infected with VHRN, rhinovirus and enterovirus are filling hospitals lately.

As NBC News reported, Pfizer said it intends to sell its COVID-19 vaccine at a price of $110 to $130 consistent with the dose for teens and adults once the U. S. government is in charge. Or health insurance would pay only a fraction of the charge or nothing at all. The charges are in line with charges for other vaccines, according to the CDC.

The CDC’s most recent follow-up shows that the BQ. 1 and BQ. 1. 1 coronavirus variants in combination account for 16. 6% of all COVID-19 cases in the United States. This is the highest proportion of infections at the time after BA. 5, accounting for 62. 2%. Eric Topol, MD, professor of molecular medicine at Scripps Research and founder and director of the Scripps Research Translational Institute, recently tweeted that BQ. 1. 1 specifically has “marked immune evasion properties, making it the number one driving force of the upcoming U. S. wave in the coming weeks.

As recorded by the European Centre for Disease Prevention and Control (ECDC), at least five European countries detected the flow of the BQ. 1 coronavirus variant the week of October 3-9. The ECDC model predicts that BQ1 and its sublineage BQ1. 1 will become the dominant coronavirus strains in Europe from mid-November to early December 2022. The European countries with the highest proportions of BQ variants are France (19%), Belgium (9%), Ireland (7%), the Netherlands (6%). ) and Italy (5%). The ECDC said initial studies recommend that BQ. 1 has the ability to particularly evade the immune formula response, but there is still no evidence that BQ. 1 is linked to greater severity of infection compared to circulation. omicron variants BA. 4 and BA. 5.

In a study of active-duty US Army personnel, approximately one-third of other people who contracted COVID-19 reported new or increased difficulty with exercise and daily activities one month after diagnosis, which recovered at pre-COVID six to nine months after illness, according to studies presented at IDWeek (October 19-23). ID Week is the joint annual meeting of the Infectious Diseases Society of America (IDSA), the Society for Health Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS) and the Society of Infectious Disease Pharmacists (SIDP). Among active-duty test participants, 39% of those who were swollen said their mandatory fitness check scores were affected, and a further 34% reported their fitness check scores were affected one year after infection. “Even in a younger, sometimes healthier population like the US military, the effects of COVID-19 can linger for months and months,” said presenter Stephanie Richard, PhD, an epidemiologist at the Foundation. Henry. Mr. Jackson for the advancement of military medicine. The study did note, however, that vaccination reduced the risk of those reported physical complications.

Speaking on former White House COVID-19 pandemic adviser Andy Slavitt’s In the Bubble podcast, Katelyn Jetelina, MD, founder and newsletter Your Local Epidemiologist, said it’s “90% likely” that the U. S. will be in the U. S. is strongly following Europe as cases continue to rise. Jetelina is involved in the significant construction of new cases in Germany, where Oktoberfest celebrations have recently been held. “It’s spreading like wildfire there,” he said.

On Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus PhD said the WHO Emergency Committee’s view on COVID-19 is that the coronavirus remains a public health emergency of foreign concern. The committee under pressure wants to monitor and expand access to testing. , remedies and vaccines for those most at risk, and for all countries to update their national preparedness and response plans. “and uncertainties,” Dr. Ghebreysus said. This pandemic has already surprised us and it is very possible that it will happen again. “

The CDC’s Advisory Committee on Immunization Practices (ACIP) voted Wednesday to raise COVID-19 shots to the Vaccines for Children program that promises loose shots for uninsured or Medicaid-eligible children, according to Kaiser Health News. In a press release, the CDC said it only makes recommendations for vaccine use, while school-based vaccination needs are decided through state or local jurisdictions.

“ACIP’s advice to include COVID-19 vaccines in the routine vaccination schedule represents another step in the country’s recovery,” the fitness firm wrote, adding that it is vital to note that there are no adjustments to COVID-19 vaccination policy. The action is only helping to streamline clinical guidance for physical care providers by aggregating all licensed, licensed and recently updated vaccines into one document. “

Updated schedules and program rules will be published in early 2023. CDC said it will continue to update and work with fitness departments, providers, and other partners in the coming months to make the COVID-19 vaccination program a smooth transition from emergency response to a regimen immunization program activity.

In a press release issued this week, biotech company Novavax announced that its COVID-19 vaccine recall obtained an Emergency Use Authorization (EUA) from the FDA. CDC Director Rochelle Walensky, MD, also signed a resolution note authorizing Novavax monovalent COVID-19 boosters for adults. This action gives others over the age of 18 the option to get a monovalent booster from Novavax instead of an upgraded (bivalent) booster from Pfizer-BioNTech or Moderna if they have finished vaccination number one but have not yet done so. won a COVID-19 booster, and if they can’t or don’t want to get mRNA vaccines. Some may not be able to obtain an mRNA vaccine because of an allergy to a component of a COVID-19 mRNA vaccine, or because of a history of a severe allergic reaction (such as anaphylaxis) after a previous dose of a COVID-19 mRNA vaccine, or lack of availability of an mRNA vaccine.

The Washington Post’s investigation into CDC data found that, at the beginning of the pandemic, black people were three times more likely to die from COVID-19 than their white peers. After the peak of the delta variant in September 2021, racial differences began to be replaced. The Post’s investigation found that deaths of black Americans declined, while deaths of white Americans slowly increased until whites died at a higher rate. While the explanation for why this substitution is not entirely explainable, the article notes that a larger conservative white population would likely have refused vaccination while more blacks accepted the vaccine.

The Center for Infectious Disease Research and Development shared the initial results of a clinical trial published in the New England Journal of Medicine that showed two doses of the Moderna COVID-19 vaccine were safe in children 6 months to 5 years old and triggered a similar immune system. System. a reaction and coverage against infection as seen in young adults.

In a study of more than 15,000 children older than 2 months to 18 years hospitalized with COVID-19 from March 2020 to March 2022, scientists found that 7% had COVID-related neurological headaches. The most common neurological headaches were fever-related seizures (3. 9%), non-fever-related seizures (2. 3%), and encephalopathy or brain disease that alters brain function or design (2. 2%). The research, published in the journal Pediatrics on Oct. 20, concluded: “Neurological headaches are not unusual in youth hospitalized with COVID-19 and are linked to worse hospital outcomes. Our findings highlight the importance of immunization against COVID-19 in young people, that is, in high-risk populations, such as those with neurological comorbidity.

NBC News reported on correspondence published Wednesday in the New England Journal of Medicine suggesting that the BA. 4. 6 subvariant could lead to reinfections. antibodies intended to neutralize BA. 4. 6 were about twice as weak as antibodies opposed to BA. 5.

On Tuesday, the FDA granted emergency use authorization for the first over-the-counter home COVID-19 control that allows the use of a saliva sample. nasal swab, according to your preference. People 14 and older can collect samples themselves, and adults can administer the check to youth ages 2 to 14.

Although this type of PCR (polymerase chain reaction) test is considered a reliable and accurate test to detect an active infection, according to the Cleveland Clinic, the FDA warns that negative effects do not guarantee that a user does not have the coronavirus. “Negative verification effects should be considered in the context of a user’s recent exposures, history, and presence of clinical symptoms and symptoms consistent with COVID-19, and are shown through additional verification, if applicable,” the fitness firm wrote.

Although the U. S. While the U. S. has recently noticed a general downward trend in the number of coronaviruses, KLAS research on knowledge of the state fitness branch in Nevada shows that average daily infections in the state increased 17% this week compared to last. In Clark County, the backlog is 20% higher. KLAS reported that wastewater monitoring reports had not been updated since last week, however, the most recent readings in the Las Vegas Valley had measured accumulations.

On Wednesday, Moderna released new clinical data on its bivalent recall containing omicron, demonstrating that the new vaccine maintains an impressive antibody reaction against the coronavirus 3 months after the company’s original booster shot. In addition to creating particularly superior neutralizing antibody reactions opposed to omicron variants BA. 4 and BA. 5, inoculation also produced a potent opposite reaction to omicron BA. 2. 75 28 days after administration.

“Given that COVID-19 remains a global risk and one of the leading causes of death worldwide, this is an encouraging development that shows that a bivalent booster dose will provide coverage before the winter months,” said Stéphane Bancel, CEO of Moderna. The company said full knowledge of the studies will be presented this week at the IDWeek conference. IDWeek is the joint annual assembly of the Infectious Diseases Society of America (IDSA), the Health Epidemiology Society of America (SHEA), the HIV Medical Association (HIVMA), the Society of Pediatric Infectious Diseases (PIDS), and the Society of Infectious Disease Pharmacists (SIDP).

Tuesday’s weekly WHO update indicated that the number of viruses continues its downward trend worldwide, with global infections dropping 6% in the week of October 10-16. However, the Western Pacific Region is an exception, with cases increasing by 11%. . Singapore, Vietnam and Brunei recorded the largest proportional increases.

Singapore’s Ministry of Health said that over the past month, COVID-19 cases have increased, basically due to the XBB omicron subvariant. XBB was first detected in August 2022 in India and has since been detected in more than 17 countries, adding Australia, Bangladesh, Denmark, India, Japan and the United States. While observations from countries where XBB has been reported recommend that it is at least as transmissible as variants circulating lately, there is no evidence that XBB causes more severe disease. According to Fortune, just so far, a handful of XBB instances have been detected in the US. U. S.

The WHO said it is tracking XBB and emerging variants a lot. However, the fitness organization noted that “preliminary laboratory evidence suggests that XBB is the most elusive variant of SARS-CoV-2 in antibodies known to date. “

According to a Reuters review of ClinicalTrials. gov and interviews with COVID-19 researchers, at least 4 clinical trials are planned to evaluate naltrexone (a generic drug usually used to treat alcohol and opioid dependence) as a long-term remedy for COVID. Evidence suggests the drug could help relieve the pain, fatigue and mental confusion symptoms of the months some patients continue to have months after a coronavirus infection.

Each year in the United States, many women die from headaches similar to those of pregnancy and childbirth, called maternal deaths. Analysis of CDC data from the U. S. Government Accountability OfficeThe U. S. Food and Drug Administration (PDF) shows that maternal deaths are more prevalent in the pandemic. In addition, data released this month shows that COVID-19 contributed to a quarter of all maternal deaths in 2020 and 2021 combined. The report highlighted racial and ethnic disparities. The maternal mortality rate for black or African American women (non-Hispanic or Latina) was 44 consistent with 100,000 live births in 2019, then increased to 55. 3 in 2020 and 68. 9 in 2021. In contrast, white women (non-Hispanic or Latina) had died. Rates of 17. 9, 19. 1, and 26. 1 consistent with 100,000 live births, respectively.

By subscribing, you agree to the Terms of Use and Privacy Policy.

Leave a Comment

Your email address will not be published. Required fields are marked *